New pill could let women start labor at home, avoiding hospital stays
NCT ID NCT05177510
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 26 times
Summary
This study tests if the drug mifepristone can safely and effectively start labor in pregnant women so they can stay home longer instead of being admitted to the hospital. About 400 women with a full-term, single baby and an unready cervix will take the pill and be monitored. The goal is to see if this approach reduces hospital time and improves the birth experience.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR, INDUCED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chelsea and Westminster Hospital
RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.